Resources

Publications

12/04/2020
- Oncology
Novel Genomic Variants and Pathways Associated With Baseline Serum Thymidine Kinase 1 Levels in HR-Positive HER2-Negative MBC Patients Commencing Palbociclib and Letrozole
SABCS Annual Meeting 2020
12/01/2020
- Oncology
Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy
11/01/2020
- Oncology
Safety and Efficacy of a Randomized Phase I Trial to Evaluate Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-small Cell Lung Cancer (COSINR Study)
ASTRO Annual Meeting 2020
10/19/2020
- Oncology
Targeted Next-Generation Sequencing (NGS) of 105 Cancer-Related Genes in Circulating Tumor DNA (ctDNA) From Patients With Advanced Cancers Treated With Immune Checkpoint Inhibitors (iCPI)
AACR Tumor Immunology and Immunotherapy 2020
10/02/2020
- Oncology
Complete Response in a Patient With Chemorefractory EGFR-Amplified, PD-L1–Positive Metastatic Gastric Cancer Treated By Dual Anti-EGFR and Anti–PD-1 Monoclonal Antibody Therapy
JCO Precision Oncology
08/19/2020
- Oncology
First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer
Clinical Colorectal Cancer
07/17/2020
- Oncology
Global Activation of Oncogenic Pathways Underlies Therapy Resistance in Diffuse Midline Glioma
Acta Neuropathologica Communications
06/11/2020
- Oncology
Molecular Analysis of Atypical Deep Penetrating Nevus Progressing to Melanoma
Journal of Cutaneous Pathology
06/03/2020
- Oncology
Development and Characterization of Patient-Derived Xenografts from Non-Small Cell Lung Cancer Brain Metastases
bioRxiv
05/15/2020
- Oncology
Recurrent Transcriptionally Active ESR1 Fusions Render Therapeutic Vulnerabilities to Kinase Inhibition in Advanced Breast Cancer
American Association for Cancer Research Annual Meeting 2020

54 55 56